Abstract:Background Several pioneering studies have provided evidence for the introduction of universal pulse oximetry screening for critical congenital heart disease. However, whether the benefits of screening reported in studies from high-income countries would translate with similar success to low-income countries is unknown. We assessed the feasibility and reliability of pulse oximetry plus clinical assessment for detection of major congenital heart disease, especially critical congenital heart disease, in China.Methods We did a pilot study at three hospitals in Shanghai to assess the accuracy of pulse oximetry plus clinical assessment for detection of congenital heart disease. We made a data collection plan before recruitment. We then undertook a large, prospective, and multicentre screening study in which we screened all consecutive newborn babies (aged 6-72 h) born at 18 hospitals in China between Aug 1, 2011, and Nov 30, 2012. Newborn babies with positive screen results (either an abnormal pulse oximetry or abnormal clinical assessment) were referred for echocardiography within 24 h of screening. We identified false-negative results by clinical follow-up and parents' feedback. We calculated sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios for pulse oximetry alone, and in combination with clinical assessment, for detection of major and critical congenital heart disease.Findings In the pilot study, 6785 consecutive newborn babies were screened; 46 of 49 (94%) cases of asymptomatic major congenital heart disease and eight of eight (100%) cases of asymptomatic critical disease were detected by pulse oximetry and clinical assessment. In the prospective multicentre study, we screened 122 738 consecutive newborn babies (120 707 asymptomatic and 2031 symptomatic), and detected congenital heart disease in 1071 (157 critical and 330 major). In asymptomatic newborn babies, the sensitivity of pulse oximetry plus clinical assessment was 93 2% (95% CI 87 9-96 2) for critical congenital heart disease and 90 2% (86.4-93.0) for major disease. The addition of pulse oximetry to clinical assessment improved sensitivity for detection of critical congenital heart disease from 77.4% (95% CI 70 0-83.4) to 93 2% (87 9-96.2). The false-positive rate for detection of critical disease was 2.7% (3298 of 120 392) for clinical assessment alone and 0 3% (394 of 120 561) for pulse oximetry alone.Interpretation Pulse oximetry plus clinical assessment is feasible and reliable for the detection of major congenital heart disease in newborn babies in China. This simple and accurate combined method should be used in maternity hospitals to screen for congenital heart disease.Funding Key Clinical Research Project sponsored by Ministry of Health, Shanghai Public Health Three-Year Action Plan sponsored by Shanghai Municipal Government, and National Basic Research Project of China.

A Public Health Economic Assessment of Hospitals' Cost to Screen Newborns for Critical Congenital Heart Disease

Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit

Pulse Oximetry and Auscultation for Congenital Heart Disease Detection

Screening of Newborn by Pulse Oximetry at Birth for the Critical Congenital Heart Disease

Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country

Pulse Oximetry Screening and Critical Congenital Heart Disease in the State of Oregon

The Performance of Critical Congenital Heart Disease Screening in Rural Versus Urban Locations in the Northwest United States

Critical Congenital Heart Disease Detection in the Screening Era: Do Not Neglect the Examination!

Neonatal Pulse Oxymetry Screening for Detection of Congenital Heart Disease in Asymptomatic Newborns: A Cross-sectional Study from a Tertiary Care Hospital

Pulse Oximetry with Clinical Assessment to Screen for Congenital Heart Disease in Neonates in China: a Prospective Study

Pulse Oximetry Screening of Newborn for Critical Congenital Heart Disease in Developing Countries

Newborn Screening for Critical Congenital Heart Disease in a Low-Resource Setting; Research Protocol and Preliminary Results of the Tanzania Pulse Oximetry Study

Pulse Oximetry Screening Has Not Changed Timing of Diagnosis or Mortality of Critical Congenital Heart Disease

Early Pulse Oximetry Screening for Congenital Heart Disease in Asymptomatic NewbornInfants

Use of Pulse Oximetry Pulsatility Index Screening for Critical Congenital Heart Disease

Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates

Evaluating the Modified American Academy of Pediatrics Screening Algorithm for Critical Congenital Heart Disease

Neonatal Pulse Oximetry Screening for Congenital Heart Disease

Critical congenital heart disease screening with a pulse oximetry in neonates

Pulse Oximetry Could Significantly Enhance the Early Detection of Critical Congenital Heart Disease in Neonatal Intensive Care Units

Newborn Critical Congenital Heart Disease Screening Using Pulse Oximetry: Value and Unique Challenges in Developing Regions